Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes

Published:2010-10 Issue:18 Volume:56 Page:1456-1462
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Storey Robert F.,Angiolillo Dominick J.,Patil Shankar B.,Desai Bhaloo,Ecob Rosemary,Husted Steen,Emanuelsson Hakan,Cannon Christopher P.,Becker Richard C.,Wallentin Lars

Funder

AstraZeneca

Daiichi-Sankyo/Eli Lilly

Schering-Plough

Novartis

Teva

Brisol-Myers Squibb/Sanofi

The Medicines Co.

Dynabyte

GlaxoSmithKline

Otsuka

Eli Lilly Co.

Daiichi-Sankyo Inc.

Portola

Accumetrics

Eisai

Johnson & Johnson

Bristol-Myers Squibb/Sanofi Partnership

Intekrin Therapeutics

Merck

Takeda

Boehringer-Ingelheim

Bristol-Myers Squibb

Lilly

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes;Storey;J Am Coll Cardiol,2007

2. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET Study;Gurbel;Circulation,2009

3. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives;Angiolillo;J Am Coll Cardiol,2007

4. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

5. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease;Angiolillo;Circulation,2007

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Bioequivalence of a Generic Ticagrelor 90‐mg Formulation Versus the Innovator Product in Healthy White Subjects Under Fasting Conditions;Clinical Pharmacology in Drug Development;2024-09-10

2. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

3. Ticagrelor monotherapy after acute coronary syndrome: lessons from the ULTIMATE-DAPT trial;Future Cardiology;2024-08-12

4. Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation;Expert Review of Cardiovascular Therapy;2024-07

5. Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary Syndrome;JACC: Cardiovascular Interventions;2024-06